These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20811691)
1. Association between metalloproteinases 2 and 9 activity and ERK1/2 phosphorylation status in head and neck cancers: an ex vivo study. Garavello W; Maggioni D; Nicolini G; Motta L; Tredici G; Gaini R Oncol Rep; 2010 Oct; 24(4):1073-8. PubMed ID: 20811691 [TBL] [Abstract][Full Text] [Related]
2. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways. Luo Y; Liang F; Zhang ZY Biochemistry; 2009 Mar; 48(8):1838-46. PubMed ID: 19199380 [TBL] [Abstract][Full Text] [Related]
3. Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells. Koontongkaew S; Amornphimoltham P; Monthanpisut P; Saensuk T; Leelakriangsak M Med Oncol; 2012 Jun; 29(2):690-703. PubMed ID: 21380786 [TBL] [Abstract][Full Text] [Related]
4. Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC‑α/ERK1/2 pathway: An in vitro investigation. Cheng XD; Gu JF; Yuan JR; Feng L; Jia XB Mol Med Rep; 2015 Dec; 12(6):7992-8002. PubMed ID: 26498639 [TBL] [Abstract][Full Text] [Related]
5. Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6. Van Tubergen EA; Banerjee R; Liu M; Vander Broek R; Light E; Kuo S; Feinberg SE; Willis AL; Wolf G; Carey T; Bradford C; Prince M; Worden FP; Kirkwood KL; D'Silva NJ Clin Cancer Res; 2013 Mar; 19(5):1169-79. PubMed ID: 23349315 [TBL] [Abstract][Full Text] [Related]
6. A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway. Wakasaki T; Masuda M; Niiro H; Jabbarzadeh-Tabrizi S; Noda K; Taniyama T; Komune S; Akashi K Neoplasia; 2010 Oct; 12(10):789-96. PubMed ID: 20927317 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study. Pietruszewska W; Bojanowska-Poźniak K; Kobos J Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931 [TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Franchi A; Santucci M; Masini E; Sardi I; Paglierani M; Gallo O Cancer; 2002 Nov; 95(9):1902-10. PubMed ID: 12404284 [TBL] [Abstract][Full Text] [Related]
11. Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells. Kaomongkolgit R; Cheepsunthorn P; Pavasant P; Sanchavanakit N Oral Oncol; 2008 Jun; 44(6):587-94. PubMed ID: 17936676 [TBL] [Abstract][Full Text] [Related]
12. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway. Poudel B; Lee YM; Kim DK Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro. Aderhold C; Umbreit C; Faber A; Birk R; Sommer JU; Hörmann K; Schultz JD Anticancer Res; 2014 Sep; 34(9):4929-37. PubMed ID: 25202075 [TBL] [Abstract][Full Text] [Related]
14. [Baicalein induces HeLa cell growth inhibition by down-regulation of matrix metalloproteinases and activating extracellular signal-regulated kinase]. Yu X; Lu K; Xia J; Mao X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):798-801. PubMed ID: 25108429 [TBL] [Abstract][Full Text] [Related]
15. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Albanell J; Codony-Servat J; Rojo F; Del Campo JM; Sauleda S; Anido J; Raspall G; Giralt J; Roselló J; Nicholson RI; Mendelsohn J; Baselga J Cancer Res; 2001 Sep; 61(17):6500-10. PubMed ID: 11522647 [TBL] [Abstract][Full Text] [Related]
16. Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF. Tong M; Lloyd B; Pei P; Mallery SR J Cell Biochem; 2008 Dec; 105(5):1202-10. PubMed ID: 18802921 [TBL] [Abstract][Full Text] [Related]
17. Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis. Kim J; Kang SM; Oh SY; Kang SH; Lee I; Hwang JC; Lee HJ; Choi SY; Hong SH Cell Physiol Biochem; 2018; 50(5):1869-1881. PubMed ID: 30396177 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling. Ding C; Tang W; Fan X; Wang X; Wu H; Xu H; Xu W; Gao W; Wu G Cell Death Dis; 2018 Jul; 9(8):802. PubMed ID: 30038287 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells. Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158 [TBL] [Abstract][Full Text] [Related]
20. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling. Hehlgans S; Eke I; Cordes N Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]